MXPA06008185A - Retinoid-containing preparations - Google Patents

Retinoid-containing preparations

Info

Publication number
MXPA06008185A
MXPA06008185A MXPA/A/2006/008185A MXPA06008185A MXPA06008185A MX PA06008185 A MXPA06008185 A MX PA06008185A MX PA06008185 A MXPA06008185 A MX PA06008185A MX PA06008185 A MXPA06008185 A MX PA06008185A
Authority
MX
Mexico
Prior art keywords
weight
soluble
acid
water
oil
Prior art date
Application number
MXPA/A/2006/008185A
Other languages
Spanish (es)
Inventor
Ptock Arne
Jentzsch Axel
Original Assignee
Basf Aktiengesellschaft
Jentzsch Axel
Ptock Arne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft, Jentzsch Axel, Ptock Arne filed Critical Basf Aktiengesellschaft
Publication of MXPA06008185A publication Critical patent/MXPA06008185A/en

Links

Abstract

The invention relates to preparations containing a) at least one type of retinoid, b) at least one type of water-soluble antioxidant, c) at least one type of oil-soluble antioxidant and d) at least 0.01 to 10%by weight of UV filter. Said invention is characterised in that the inventive preparations contain at least 1 part by weight of one or several water-soluble antioxidants and 0.1 to 100 parts by weight of one or several oil-soluble antioxidants per part by weight of retinoid, the content of one or several water-soluble antioxidants ranging from 0.05 to 0.8%by weight with respect to the total quantity of the preparations.

Description

PREPARATIONS CONTAINING RETINOIDS The present invention relates to preparations containing retinoids, their preparation and use in cosmetics and pharmacy.
Retinoids are some of the most active ingredients used in cosmetics and dermatology, these have, among others, a regulatory effect on the growth of normal cells and influence the differentiation of epithelial cells. The retinoic acids are thus used for the treatment of acne, and retinol is used in anti-wrinkle creams.
However, the use of retinoids is very restricted, which can be attributed, among other things, to the high instability of the compounds. For this reason, rigorous safety precautions have been observed during the production of the retinoid-containing preparations. For example, the production can be carried out completely under protective gas, and the finished product must be packed in light and oxygen impermeable packaging.
These requirements require the manufacturer to have complex technology equipment and in this way are associated with high production costs.
Some methods to stabilize retinoids have been described. For example, EP-A-1 056 720 describes the stabilization of oxygen sensitive compounds using thio compound or glycoproteins with the exclusion of oxygen.
According to WO 93/00085 and EP-A-0 440 398, the antioxidants soluble in water and also in fats are used together with chelating agents for the stabilization of retinoids.
However, the described methods do not always lead to adequate stabilization for the purpose of the invention. In contrast, water-soluble antioxidants, in particular ascorbic acid, and fat-soluble antioxidants, in particular tocopherol, have a destabilizing effect in relation to retinoids in some concentration ranges.
In addition, in some cases, the use of some antioxidant combinations together with the retinoids may give rise to unwanted side effects, for example, yellowish discolorations of the preparations, which makes the use of these systems in the cosmetics sector unlikely or in food.
Therefore, an object of the present invention was to provide preparations containing retinoids which do not have the disadvantages mentioned above with respect to stability and discoloration, and which can be produced in a simple form.
The goal is achieved through preparations that contain: to. at least one retinoid, b. at least one water-soluble antioxidant, c. at least one oil-soluble antioxidant and d. 0.01 to 10% by weight of at least one UV filter. wherein, in the preparations, for each part by weight of retinoid there is present at least one part by weight of one or more water-soluble antioxidants and 0.1 to 100 parts by weight of one or more oil-soluble antioxidants, wherein the content of one or more water-soluble antioxidants is in the range from 0.05 to 0.8% by weight, based on the total amount of the preparations.
The preparations according to the invention are pharmaceutical cosmetic and dermatological preparations. Preference is given to cosmetic preparations, in particular preparations for skin care.
An advantageous embodiment of the preparations according to the invention contains, by weight of the retinoid, 1 to 100 parts by weight, preferably 1 to 20 parts by weight, particularly preferably 1 to 6 parts by weight, very particularly preferably 3 to 5 parts by weight of one or more water-soluble antioxidants, and 1 to 20 parts by weight, preferably 1 to 15 parts by weight, particularly preferably 1 to 10 parts by weight, very particularly preferably 3 to 5 parts by weight by weight of one or more oil soluble antioxidants.
For the purpose of the present invention, retinoids means the alcohol of vitamin A (retinol) and its derivatives, such as the aldehyde of vitamin A (retinal), the acid of vitamin A (retinoic acid) and esters of vitamin A, such as retinyl acetate and retinyl palmitate. The term "retinoic acid" herein consists of all-trans retinoic acid and 13-cis-retinoic acid. The terms retinol and retinal preferably comprise the all trans compounds. The preferred retinoid used for the preparations according to the invention is all-trans-retinol.
The proposed water-soluble antioxidants are, among others, ascorbic acid, sodium sulfite, sodium metabisulfite, sodium bisulfite, sodium thiosulfite, formaldehyde sodium sulfoxide, isoascorbic acid, thioglycerol, thiosorbitol, thiourea, thioglycolic acid, cysteine hydrochloride. , 1,4-diazobicyclo (2,2,2) octane and mixtures thereof.
Preferred water soluble antioxidants are ascorbic acid (L-ascorbic acid) and isoascorbic acid (D-ascorbic acid), particularly preferably L-ascorbic acid.
The L-ascorbic acid which is used with particular preference may be the free acid or even the salts thereof. Examples of the salts of L-ascorbic acid are the alkali metal or alkaline earth metal salts of L-ascorbic acid, such as sodium L-ascorbate, potassium L-ascorbate or calcium L-ascorbate, but also salts of L-ascorbic acid with an organic amino compound, such as choline ascorbate or L-carnitine ascorbate. Particular preference is given to the use of free L-ascorbic acid or sodium L-ascorbate. The corresponding statements apply to the use of D-ascorbic acid.
The proposed oil-soluble antioxidants include, but are not limited to, butylated hydroxytoluene (BHT), ascorbyl palmitate, butylated hydroxyanisole, α-tocopherol, phenyl-α-naphthylamine or mixtures thereof.
A preferred oil-soluble antioxidant is α-tocopherol, which may be (R, R, R) - or (all-rae) -a-tocopherol.
For the purpose of the present invention, UV filter means UV-A, UV-B and / or wide-band filters.
Advantageous broadband filters, UV-A or UV-B filter substances are, for example, representative of the following classes of compounds: bis-resorcinyltriazine derivatives with the following structure: where R1, R2 and R3, independent of each other, are chosen from branched and unbranched alkyl groups having 1 to 10 carbon atoms or 1 individual hydrogen atoms. Particular preference is given to compound 2, -bis-. { [4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine (INCI: Aniso Triazine), which is available under the trademark Tinosorb® S from CIBA-Chemikalien GmbH.
Other UV filter substances, which have the structural motif: also are their advantageous UV filter substances within the meaning of the present invention, for example, the S-triazine derivatives described in the European specification open to the public EP 570 838 Al, the chemical structure that is given by the generic formula: where : R is a branched or unbranched Ci-Ciß alkyl radical, a C5-C12 cycloalkyl radical, optionally substituted by one or more C1-C4 alkyl groups.
X is an oxygen atom or an NH group, Ri is a branched or unbranched C? -Ci8 alkyl radical, a C5-C12 cycloalkyl radical? optionally substituted by one or more C3-C4 alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula: in which: A is a branched or unbranched C? -Ci8 alkyl radical, a C5-C12 cycloalkyl radical or aryl, optionally substituted by one or more C1-C4 alkyl groups.
R3 is a hydrogen atom or a methyl group, n is a number from 1 to 10, R2 is a branched or unbranched Ci-Cis alkyl radical, a C5-C12 cycloalkyl radical, optionally substituted by one or more C1-C4 alkyl groups, if X is the NH group, a branched C1-C18 alkyl radical or unbranched, a C5-C12 cycloalkyl radical, optionally substituted by one or more C1-C alkyl groups or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula: in which: A is a branched or unbranched Ci-Ciß alkyl radical, a C5-C12 cycloalkyl radical or aryl radical, optionally substituted by one or more C1-C4 alkyl groups.
R3 is a hydrogen atom or a methyl group, n is a number from 1 to 10, if X is an oxygen atom.
A particularly preferred UV filter substance within the meaning of the present invention is also an asymmetrically substituted s-triazine whose chemical structure is given by the formula: which is also referred to later as dioctylbutyl to idotriazone (INCI: diethylhexylbutanedi triazone) and is available with the brand UVASORB® HEB from Sigma 3V.
Also advantageous within the meaning of the present invention is an s-triazine, symmetrically substituted, tris (2-ethylhexyl) 4 ', 4"- (1, 3, 5-triazine-2, 4, 6-triazine-2 ,, 6-triiltriiamino) trisbenzoato, syn: 2, 6-tris [anilino (p-carbo-2'-ethyl-1'-hexyloxy)] -1, 3, 5-triazine (INCI: Ethylhexyl triazone) sold by BASF Aktiengesellschaft under the brand UVINUL® T 150.
The European specification open to the public 775 698 also describes derivatives of bisresorcinyltriazine to be used with preference, the chemical structure of which is given by the generic formula: where Ri and R2 are, inter alia, C3-C18 alkyl or C2-C18 alkenyl and i is an aromatic radical.
Also advantageous for the purpose of the present invention are 2, 4-bis. { [4- (3-sulfonate) -2-hydroxypropyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, the sodium salt, 2, 4-bis. { [4- (3- (2-propyloxy) -2-hydroxypropyloxy) -2-hydroxy] phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis. { 4- (2-ethylexyloxy) -2-hydroxy] phenyl} -6- [(2-methoxyethylcarboxyl) phenylamine] -1,3,5-triazine, 2,4-bis. { [4- (3- (2-propyloxy) -2-hydroxypropyloxy) -2-hydroxyphenyl} -6- (4- (2-ethylcarboxyl) phenylamine] -1,3,5-triazine, 2,4-bis { [4- (2-ethylhexyloxy) -2-hydroxy] phenyl] -6- (l-methylpyrrole-2-yl) -1,3,5-triazine, 2,4-bis { [4-tris (trimetilsiloxisililpropiloxi) -2-hydroxy] -phenyl.}. -6- (4-methoxyphenyl ) -l, 3,5-triazine, 2,4-bis { [4- (2"-methylpropenyloxy) -2-hydroxy] phenyl.}. -6- (4-methoxyphenyl) -1,3,5 -triazine, and 2, 4-bis { [4- (1 ', 1', 1 ', 3', 5 ', 5', 5 '-heptamethylsiloxy-2"-methylpropyloxy) -2-hydroxy] phenyl.}. -6- (4-methoxyphenyl) -1,3,5-triazine.
Water soluble, sulfonated UV filters, advantageous for the purpose of the present invention are: phenylene-1,4-bis (2-benzimidazyl) -3,3 '-5,5'-tetrasulfonic acid, which is characterized by the following structure: and their salts, particularly the corresponding sodium, potassium and triethanolammonium salts, in particular the bis-sodium salt of phenylene-1,4-bis (2-benzimidazyl) -3,3'-5, 5'-tetra-sulphonic acid. with the INCI name bisimidazilate (CAS No .: 180898-37-7), which can be obtained, for example, with the Neo Heliopan® AP from Haarmann & Reimer Another UV filter sulfonated advantageous for the purpose of the present invention are salts-phenylbenzimidazole-5-sulphonic acid 2, such as its sodium, potassium or triethanolammonium salt, and the sulphonic acid itself: with the name INCI phenylbenzimidazole sulfonic acid (CAS No .: 27503-81-7), which can be obtained, for example, under the trademark Eusolex® 232 from Merck or with the Neo Heliopan® Hydro from Haarmann & Reimer Another UV filter sulfonated advantageous is 3, 3 '- (1, 4-fenilendimetilen) bis (7, 7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1-ilmetansulfónico, such as its sodium salt , potassium or triethanolammonium, and the sulphonic acid itself: with the name INCI acid tereftaliden dicamfor sulphonic (CAS No .: 90457-82-2), which can be obtained, for example, from the brand Mexoryl® SX Chimex.
Another UV-B and / or broadband filter soluble in water, the substances are advantageous, for example: sulphonic acid derivatives of 3-benzilidencanfor, such as for example 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulphonic acid and salts these.
UV-B and / or wide-band filters can be oil-soluble or water-soluble. Advantageous oil-soluble UV-B and / or wide-band filter substances are, for example: 3-benzylidenecamphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidenecamphor; 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoate of (2-ethylhexyl), 4- (dimethylamino) benzoate of amyl, 4-bis (polyethoxy) aminobenzoate of polyethoxyethyl (can be obtained under the trademark Uvinul® P25 from BASF ); benzophenone derivatives, preferably 2-hydroxy-4-methoxybenzophenone (obtainable from the Uvinul® M40 trademark of BASF), 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, acid 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid (available from Uvinul® MS40 from BASF), 2, 2 ', 4,4'-tetrahydroxybenzophenone (available from Uvinul® D 50 from BASF); UV filters attached to polymers.
For the purpose of the present invention, particularly advantageous UV filter substances which are liquid at room temperature are homomenthyl salicylate, 2-cyano-3, 3-diphenylacrylate 2-ethylhexyl, ethylhexyl 2-hydroxybenzoate and cinnamic acid esters, preferably 2-methylhexyl 4-methoxycinnamate and isopentyl 4-methoxycinnamate.
Homomenthyl salicylate (INCI: homosalate) is characterized by the following structure. 2-cyano-3, 3-diphenylacrylate 2-ethylhexyl (INCI: octocrylene) can be obtained from BASF under the brand name Univul® N 539T and is characterized by the following structure: 2-ethylhexyl 2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: ethylhexyl salicylate) can be obtained, for example, from Arman & Reimer with the Neo Heliopan® OS brand and is characterized by the following structure: 2-ethylhexyl 4-methoxycinnamate (INCI: ethylhexyl methoxycinnamate) can be obtained, for example, from BASF under the trademark Uvinul® MC 80 and is characterized by the following structure: Isopentyl 4-methoxycinnamate (INCI: isoamyl p-methoxycinnamate) can be obtained, for example, from Arman & Reimer with the Neo Heliopan® E 1000 brand and is characterized by the following structure: For the purpose of the present invention, another advantageous UV filter substance which is liquid at room temperature (copolymer of (3- (4- (2,2, -bisetoxycarbonylvinyl) phenoxy) propenyl) -methylsiloxane / dimethylsiloxane, obtainable by example of Hoffmann-La Roche with the Parsol® SLX brand.
For the purposes of the present invention, the advantageous dibenzoylmethane derivatives are in particular 4- (tert-butyl) -4'-methoxydibenzoylmethanol (CAS No. 70356-09-1), which is marketed by BASF under the trademark Uvinul® BMBM and by Merck with the Eusolex® 9020 brand, which is characterized by the following structure: Another advantageous dibenzoylmethane derivative is a 4-isopropyldibenzoylmethane (CAS No. 63250-25-9), which is marketed by Merck under the trademark Eusolex® 8020. Eusolex® 8020 is characterized by the following structure: The benzotriazoles are characterized by the following structural formula: in which: R1 and R2, independent of each other, can be linear or branched alkyl radicals, saturated or unsaturated, substituted (for example substituted by a phenyl radical) or unsubstituted, having 1 to 18 carbon atoms and / or polymeric radicals by themselves they do not absorb UV rays (such as silicon radicals, acrylate radicals and the like), and R3 is selected from the group H or alkyl radical having from 1 to 18 carbon atoms.
For the purpose of the present invention, an advantageous benzotriazole is 2,2 '-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol), a filter of broad band that is characterized by the chemical structural formula: can be obtained from the Tinosorb® M brand of Ciba Chemikalien GmbH.
For the purpose of the present invention, another advantageous bezotriazole is 2- (2H-bezotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1, 3, 3, 3-tetramethyl-l- [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol (CAS No .: 155633-54-8) under the name INCI Drometrizol Trisiloxane, which is marketed by Chimex under the trademark Mexoryl® XL and is characterized by the following structural chemical formula : For the purpose of the present invention, other advantageous benzotriazoles are: [2, '-dihydroxy-3- (2H-benzotriazol-2-yl) -5- (1, 1, 3, 3-tetramethylbutyl) -2'-N -octoxy-5'-benzoyl] diphenyl-methane, 2,2 '-methylenebis [6- (2H-bezotriazol-2-yl) -4- (methyl) phenol], 2'-2-methylenebis- [6- ( 2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol], 2- (2'-hydroxy-5'-octyl-phenyl) benzotriazole, 2- (2'-hydroxy) 3 ', 5' -di-t-amylphenyl) benzotriazole and 2- (2'-hydroxy-5'-methylphenyl) benzotriazole.
For the purpose of the present invention, another advantageous UV filter is the diphenylbutadiene compound of the following formula described in EP-A-0 916 335.
For the purpose of the present invention, another advantageous UV-A filter is diethyl 2- (4-ethoxyanilinomethylene) propanedicarboxylate of the following formula described in EP-A-0 895 776.
Likewise, advantageous for the purposes of the present invention, is a hydroxybenzophenone substituted with anaino of the following formula: which is marketed by BASF Aktioengelsellschanft as a UV-A filter with the UVINUL® A Plus brand.
The cosmetic and dermatological preparations according to the invention also advantageously, although not necessarily, contain inorganic pigments based on metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular titanium oxides (TiO2), zinc (ZnO), iron (for example Fe2 or 3), zirconium (Zr? 2), silicon (SIO2), manganese (for example MnO), aluminum (AI2O3), cerium (for example C? 2? 3), mixed oxides of the corresponding metals and mixtures of these oxides. These pigments are amorphous to X-rays and amorphous not to X-rays. These are particularly preferred pigments based on TiO2.
X-ray amorphous oxide pigments are metal oxides or semi-metallic oxides that, in X-ray diffraction experiments, do not reveal recognizable or non-recognizable crystal structures. These pigments can often be obtained by reaction to the flame, reacting a metal halide or semimetal halides with hydrogen and air (or pure oxygen) in a flame.
In cosmetic, dermatological or pharmaceutical formulations, amorphous X-ray oxide pigments are used as thickeners and thixotropic agents, flow aids, for stabilization of emulsions and dispersions and as carrier substances (for example to increase the volume of finely divided powders) .
The amorphous oxide pigments known to X-rays and often used in cosmetic or dermatological medicaments are silicon oxides of the Aerosil® type (CAS No. 7631-86-9). The Aerosil®, which can be obtained from DEGUSSA, are characterized by small particle size (for example between 5 and 40 nm) where the particles are considered as spherical particles of very uniform dimension. At first sight, Aerosil® can be observed as white, loose powders. For the purpose of the present invention, X-ray amorphous silicon dioxide pigments are particularly advantageous, and among these in particular those of the Aerosil® type are preferred.
Advantageous Aerosil® grades are for example Aerosil® OX50, Aerosil® 130, Aerosil® 150, Aerosil® 200, Aerosil® 300, Aerosil® 380, Aerosil® MOX 80, Aerosil® MOX 170, Aerosil® COK 84, Aerosil® R 202, Aerosil® R 805, Aerosil® R 812, Aerosil® R 972, Aerosil® 974, Aerosil® R 976.
According to the invention, the inorganic, amorphous, non-X-ray pigments are advantageously hydrophobic, ie they have been surface treated to repel water. This surface treatment may consist in providing the pigments with a thin hydrophobic layer by the methods already known.
One method is, for example, to produce the surface hydrophobic layer by a reaction in accordance with: n Ti02 + m (RO) 3 Si-R '? n Ti02 (surf.) n and m in this case are stoichiometric parameters that are used as desired, R and R 'are the desired organic radicals. Hydrophobized pigments, synthesized, for example, in accordance with DE-A 33 14 743 are advantageous.
For the purpose of the present invention, organic surface coatings may consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethyl polysiloxane (also dimethicone), methyl polysiloxane (methicone), simethicone (a mixture of dimethyl polysiloxane with an average chain length from 200 to 350 units of dimethylsiloxane and silica gel), octyltrimethoxysilane or alginic acid. These organic surface coatings can be used as they are, in combination and / or in combination with inorganic coating materials.
The zinc oxide particles and the previous dispersions of zinc oxide particles suitable according to the invention can be obtained from the following brands and from the aforementioned companies.
The suitable titanium dioxide particles and the previous dispersions of the titanium dioxide particles can be obtained from the following brands and from the following listed companies: Advantageous TiO2 pigments can be obtained, for example, from the Uvinul® TIO2 brand, the advantageous Ti02 / Fe2 + 3 mixed oxides of the Uvinul® Ti02 A brand from BASF.
The total amount of at least one UV filter used in the finished cosmetic or dermatological preparations is advantageously chosen from the range from 0.01 to 10% by weight, preferably in the range from 0.5 to 8% by weight, with particular preference in the range from 1 to 7% by weight, based on the total weight of the preparations.
The UV filters present in the preparations according to the invention can be used in this case to stabilize retinol (protection of the product) and to protect human skin against UV radiation (skin care) .
For use as protection of the product, the necessary amount of the UV filters that can be used is much smaller and for these cases it is advantageously in the range from 0.01 to 0.5% by weight, preferably in the range from 0.05 to 0.1%, based on the total weight of the preparations.
The UV filters that would be mentioned as preferred for use in the preparations according to the invention are the following: the Uvinul® brands of BASF: Uvinul® A Plus, Uvinul® D 50 Uvinul® M 40, Uvinul® MS 40, Uvinul® P 25, Uvinul® MC 80, Uvinul® N 539, Uvinul® T150, and inorganic pigments TiO 2, and ZnO.
In particular, for use as protection of the product, the following UV filters can be mentioned: Uvinul® A Plus, Uvinul® D 50 Uvinul® M 40, Uvinul® MS 40, Uvinul® MS 40 and Uvinul® P 25.
The preparations according to the invention normally contain 0.015 to 0.2% by weight, preferably 0.02 to 0.15% by weight, with particular preference 0.03 to 0.15% by weight, most particularly preferably 0.04 to 0.12% by weight, of one or more retinoids , in particular all trans retinol, 0.05 to 0.8% by weight, preferably 0.08 to 0.7% by weight, particularly preferably 0.12 to 0.6% by weight, with very particular preference 0.16 to 0.5% by weight of one or more antioxidants soluble in water, in particular L-ascorbic acid and 0.005 to 2% by weight, preferably 0.01 to 1.8% by weight, particularly preferably 0.1 to 1.5% by weight, with very particular preference 0.15 to 1.2% by weight of one or more antioxidants soluble in oil, in particular α-tocopherol.
The preparations according to the invention are characterized, among other things, in that it is possible to omit the use of protective gas during its production, filling and storage while guaranteeing adequate stability. , For the purposes of the present invention, by suitable stability it is meant that the retinoid is again in an amount of at least 90% in the preparation after storage for 12 weeks at 40 ° C. In addition, no unwanted color changes are observed during the storage of the preparations according to the invention.
It is convenient that the preparations according to the invention are stored in oxygen-impermeable containers.
Oxygen-impermeable containers can be any normal commercial container, suitable for this purpose, such as glass containers or aluminum containers.
Another advantage of the preparations according to the invention is that these products no longer have to be stored excluding light.
By comparison with the previously known retinoid-containing cosmetic preparations, when the preparations according to the invention are used in the care of the skin it is now possible to correct the increased sensitivity of the skin to sunlight often activated by the retinoid.
Cosmetic and dermatological or pharmaceutical preparations are generally based on a carrier consisting of at least one oil phase. However, only water-based preparations are also possible. Accordingly, oily, creamy, paste, stick-shaped foams or fat-free gels or preferably emulsions are suitable.
Suitable emulsions are O / W emulsions, W / O emulsions, microemulsions or multiple emulsions such as O / W / 0 emulsions or W / O / W emulsions with one or more retinoids according to the present invention in dispersed form, where the emulsions can be obtained, for example, by the phase inversion technique, as described in DE-A-197 26 121.
Customary cosmetic auxiliaries which may be suitable as additives for cosmetic or pharmaceutical preparations are, for example, coemulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, perfumes, dyes, release agents, preservatives, pigments, electrolytes (for example magnesium sulfate and pH regulators) The suitable coemulsifiers are preferably the W / 0 and also O / W emulsifiers known, such as, for example, polyglycerol esters, sorbitan esters or partially esterified glycerides. of the fats are glycerides, the waxes which may be mentioned are, inter alia, beeswax, paraffin wax or microcrystalline waxes, if appropriate in combination with hydrophilic waxes.The stabilizers used may be metal salts of fatty acids such as stearate magnesium, aluminum stearate and / or zinc stearate. Suitable thickeners are, for example, crosslinked polyacrylic acids and derivatives thereof, polysaccharides, in particular xanthan gum, guar gum, agar agar, alginates and tyloses, carboxymethylcellulose and hydroxyethylcellulose, also fatty alcohols, monoglycerides and fatty acids, polyacrylates, polyvinyl alcohol and polyvinyl pyrrolidone. Biogenic active ingredients are, for example, plant extracts, protein hydrolysates and vitamin complexes. Typical film formers are, for example, hydrocolloids such as chitosan, microcrystalline chitosan or quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and the like. Suitable preservatives are, for example, solution of formaldehyde, P-hydroxybenzoate or sorbic acid. Suitable release agents are, for example, glyceryl esters of distillers such as ethylene glycol distearate, but also fatty acids and monoglycol esters of fatty acids. The colorants that can be used are the substances approved and suitable for cosmetic use, as enlisted for example in the publication "Kosmetische Fárbemittel" [cosmetic dyes] of the Farbstoffkommission der Deutschen Forschungsgemneinschaft [Bleaching Commission of the German Research Society], published by Verlag, Chemi, Weinheim, 1984. These dyes are commonly used in a concentration from 0.001 to 0.1% by weight, based on the total mixture.
In many cases the use of other antioxidants is advantageous. Thus, in addition to the antioxidants according to the invention specified at the outset, it is possible to use all antioxidants that are customary or suitable for cosmetic and / or dermatological applications.
Antioxidants are advantageously chosen from the group consisting of amino acids (for example glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles, (for example urocanic acid) and derivatives thereof, peptides such as D, L-carnocin, D -carnocin, L-carnocin and derivatives thereof (for example anserine), carotenoids, carotenes (for example β-carotene, lycopene), and derivatives thereof, chlorophenic acid and derivatives thereof, lipoic acid and derivatives thereof (for example dihydrolipic acid), aurothioglucose, propylthiouracil, and other thiols (eg, thiorodoxin, glutathione, cystine, cystamine, and glucosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, and lauryl, palmitoyl, oleyl,? -linoleyl, cholesteryl and glyceryl esters) of these) and also the salts of these, dilaurylthio dipropionate, distearyl thiodipropionate, thiodiopropionic acid and derivatives thereof (esters, ethers, peptides, nucleotide lipids, nucleosides and their salts), and compound s sulphoximine (for example butionine sulphoximines, homocysteine sulphoximines, butionine sulfonates, pentahexa-, heptatinine sulphoximine) in very low tolerated doses (for example pool to amol / kg), also chelating agents (metal) (for example α-hydroxy-fatty acids) , palmitic acid, phytic acid, lactoferrin), α-hydroxy acid (eg citric acid, lactic acid, maleic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA and derivatives thereof, fatty acids unsaturated and derivatives thereof (for example α-linolenic acid, linolic acid, oleic acid), folic acid and its derivatives, and corniphenyl benzoate of the benzoin resin, rutinic acid and derivatives thereof, α-glycosylrutine, ferulic acid, furfurilidenglucitol, carnocin, nordihydroguaiácico acid, nordihidroguarético acid, trihidroxibutirofenona, úrico acid and derivatives of this, mannose and its derivatives, zinc and its derivatives (for example ZnO, ZnS? 4), selenium and its derivatives (for example selenomethionine), stilbenes and their derivatives (stilbene oxide, trans-stilbene oxide).
The total amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.075 to 30% by weight, with particular preference 0.01 to 20% by weight, in particular 0.55 to 10% by weight, based on the weight total of the preparation.
Oily compounds customary in cosmetics are, for example, paraffin oil, glyceryl stearate, isopropyl myristate, diispropyl adipate, cetilestearyl 2-ethylhexanoate, hydrogenated polyisobutene, petrolatum, caprylic / capric triglycerides, microcrystalline wax, lanolin and stearic acid. .
Method of production: There are various ways to produce cosmetic preparations. For example, the hot / hot method, the hot / cold method or the cold / cold method, as described for example in "Kos etic-Entwicklung, Herstellung an Anwendung kosmetischer Mittel" [Cosmetics-development, production and use of cosmetic compositions ], Wilfried U bach, Thie e Verlag, 1995, page 511. With the help of these methods it is possible to prepare oil-in-water (O / W), water-in-oil (W / O) emulsions, but also multiple emulsions and gels in creams The active ingredients are preferably incorporated after the formulation has been cooled to below 40 ° C, in particularly sensitive cases, preferably after it has cooled to room temperature. For the investigations forming the basis of this invention, an O / W emulsion was prepared in the hot / hot method and then the active ingredients were incorporated into the finished formulation at room temperature.
The formulation used was: Phase A? Ingredient INCI 2.00 Cremophor A 6 Cetearet-6, cetearyl alcohol 2.00 Cremophor A 25 Cetearet 25 3.00 Jojoba oil Simensia seed Chinensis (jojoba) Oil 3.00 Cetylstearyl alcohol Cetearyl alcohol 10.00 Paraffin oil, Viscous mineral oil 5.00 Petroleum jelly 4.00 Miglyol 812 Caprylic / capric triglyceride 0.10 BHT BHT Phase B 5.00 1, 2-tropylene glycol USP Propylene glycol 0.10 EDTA BD EDTA disodium 20.00 Carbopol 934, 1% in water Demineralized carbomer 0.30 Chemag 2000 Demineralized water and 100 Demineralized water Phase C 0.80 Sodium hydroxide 10% sodium hydroxide in demineralised water Phase D 0.50 Vitamin E acetate Tocopheryl acetate 0.20 Phenoxyethanol phenoxyethanol q. s. Perfume oil Production: Phases A and B were separately heated to approximately 80 ° C, phase B was added with stirring to phase A and homogenized. The mixture was neutralized with phase C and then homogenized. With stirring, the cream was cooled to about 40 ° C, phase D was added with stirring and the mixture was homogenized again.
The water-soluble and oil-soluble antioxidants and also the UV filters were then, after cooling the cream at room temperature, incorporated in the finished emulsion. For this, DL-alpha-tocopherol and the UV filter were first added, after the ascorbic acid or sodium ascorbate and subsequently retinol (retinol 15D®, BASF, 15% solution of retinol in a medium chain triglyceride) were added. they incorporated with agitation.
The cream was then packed in aluminum tubes with an internal protective coating or in light-permeable glass containers.
According to the production method described above, creams with different amounts of retinol, (all-rae) a-tocopherol and L-ascorbic and at least the UV filter were produced and stored during 12 weeks at 40 ° C for the stability study.
The subject of the invention was shown in greater detail with reference to the following formulations examples: Example 1 Skin lotion (O / W emulsion)% by weight Cetearet 6 and stearyl alcohol 2.50 Cetearet 25 2.50 Hydrogenated cocoglyceride 1.50 PEG-40 dodecylglycol copolymer 3.00 Dimethicone 3.00 Fenetildimethicone 2.00 Cyclomethicone 1.00 Cetearyl octanetoate 5.00 Avocado oil 1.00 Almond oil 2.00 Wheat germ oil 0.80 Pantenol USP 1.00 Fitantriol 0.20 Vitamin E acetate 0.30 Propylene glycol 5.00 Perfume c.s. Preserver c.s. Ascorbate sodium 0.20 Retinol 14D® 0.20 Tocopherol 0.10 Diethylamino hydroxybenzoyl hexyl benzoate 0.06 (Uvinul® A plus) Water c b 100 Example 2 Hand cream (W / O emulsion)% by weight Cetearyl alcohol 1.00 Glyceryl stearate 1.50 Stearyl alcohol 1.50 Paxil of cetilo 2.00 Vitamin E acetate 0.50 Dimethicone 8.00 Cetearet 6 and stearyl alcohol 3.00 Octyl methoxycinnamate 5.00 Propylene glycol 8.00 Pantenol 1.00 Primal oil 3.00 PEG-7 hydrogenated castor oil 6.00 Glyceryl Oleate 1.00 Fenetildimethicone 3.00 Beeswax 1.50 Carob seed 0.80 Silk powder 0.80 Preserver c.s. Perfume c.s. Borax 0.10 Sodium ascorbate 0.30 Tocopherol 0.60 Retinol 15D® 0.66 Benzophenone-2 (Uvinul® D50) 0.05 Water c b 100 Example 3 Lotion sunscreen (emulsion W / O)% by weight PEG-7 hydrogenated castor oil 6.00 PEG-40 hydrogenated castor oil 00.50 Palmitado of isopropilo 7.00 Copolymer PEG-45 / dodecylglycol 2.00 Jojoba oil 3.00 Magnesium stearate 0.60 Octyl methoxycinnamate 5.00 C12-C15 alkyl benzoate 5.00 Titanium dioxide 4.00 Propylene glycol 5.00 EDTA 0.20 Preserver c.s. Retinol 15D® 0.33 Water c b 100 Ascorbyl sodium phosphate 1.00 Vitamin E acetate 0.50 Ascorbate sodium 0.20 Tocoferol 1.0Q Perfume c.s.
Example 4 Multiple emulsion (emulsion W / O / W)% by weight Paraffin oil 7.50 Cetearyl octanetoate 2.50 Aluminum stearate 0.25 Magnesium stearate 0.25 Microcrystalline wax H 0.50 Cetearyl alcohol 1.00 1.50 lanolin alcohol Wool wax ointment 1.50 PEG-7 hydrogenated castor oil 0.75 PEG-45 dodecylglycol copolymer 2.00 Cetearet 6 and cetearyl alcohol 2.00 Cetearet 25 1.00 Trilauret 4 phosphate 7.50 Hydroxyethylcellulose 0.20 Propylene glycol 7.50 Magnesium sulfate 0.25 Sodium ascorbate 0.30 Tocoferol 0.01 Retinol 15D® 0.40 Diethylamino hydroxybenzoyl hexyl benzoate 0.06 (Uvinul® A Plus) Water c b 100 Example 5 Microemulsion% by weight Cetearet 25 13.00 PEG-7 glyceryl cocoate 20.00 Octyldodecanol 5.00 Preserver c.s. Sodium ascorbate 0.10 Tocopherol 0.10 Retino 15D® 0.66 Benzophenone-4 (Uvinul® M 40) 0.07 Water c b 100 Example 6 Liposome gel (hydrophilic gel)% by weight PEG-40 hydrogenated castor oil 1.00 Bisabolol rae. 0.10 Propylene glycol 8.00 Pantenol 0.50 Water Vitamin E acetate Polysorbate 80 and 3.00 caprylic / capric triglyceride and lecithin Preserver c.s. Perfume c.s. Carbonero 0.50 Sodium ascorbate 0.15 Tocopherol 0.15 Triethanolamine 0.70 Retino 15D® 0.33 Diethylamino hydroxybenzyl hexylbenzoate 0.06 (Uvinul® A PLus) Water c b 100 Example 7 Make-up (cosmetic for decoration) % in weigh Cetearet 6 and stearyl alcohol 9.00 Dimeticone 5.00 Cetearyl octaneate 8.00 Macadamia nut oil 5.00 Propylene glycol retinol 15D® 0.66 Water c b 100 Sicovit White E 171 8.00 Sicomet Brown 70 13E 3717 2.00 Ascorbate sodium 0.20 Tocopherol 0.50 Perfume c.s. Benzophenone-3 (Uvinul® M 40) 5.00 Example 8 Liquid makeup (cosmetic for decoration) % in weigh Cetearet 6 and stearyl alcohol 7.00 Cetearet 25 5.00 Dimeticone 5.00 Cetearyl octaneate 8.00 Macadamia nut oil 5.00 Propylene glycol 5.00 Retinol 15D® 0.33 Water c b 100 Sicovit White E 171 8.00 Sicomet Brown 70 13E 3717 1.00 Sodium ascorbate 0.10 Tocoferol 0.01 Perfume c.s. Benzophenone-3 (Uvinul® M 40) 5.00 Example 9 Sunscreen lotion (O / W emulsion)% by weight Cetearet 6 and stearyl alcohol 2.30 Cetearet 25 1.00 Cetyl stearyl alcohol 4.80 Cetilestearyl Octanoate 10.0 Glyceryl monostearate 3.00 Vaseline 3.00 Pantenol USP 1.00 EDTA disodium 0.20 Imidazolidinylurea 0.30 Propylene glycol 5.00 Ascorbyl 2-sodium monofofato 0.20 Vitamin E acetate 1.00 Bisabolol 0.10 Retinol 0.05 Tocopherol 0.20 Ascorbate sodium 0.20 Diethylamino hydrosxybenzoyl benzoate 2.00 (Uvinul® A Plus) ethylhexyl p-methoxycinnamate (Uvinul® MC 80) 3.00 Water c b 100

Claims (12)

  1. A preparation that contains: a. at least one retinoid, b. at least one water-soluble antioxidant, c. at least one oil soluble antioxidant and d. 0.01 to 10% by weight of at least one UV filter. wherein, during the preparation, by weight part of retinoid there is present at least one part by weight of one or more water-soluble antioxidants and 0.1 to 100 parts by weight of one or more oil-soluble antioxidants, wherein the content of one or more water-soluble antioxidants is in the range from 0.05 to 0.8% by weight, based on the total amount of the preparation.
  2. 2. The preparation according to claim 1, which is a cosmetic or pharmaceutical preparation.
  3. 3. The preparation according to one of claims 1 and 2, containing, by weight part of the retinoid, 1 to 6 parts by weight of one or more water-soluble antioxidants and 1 to 10 parts by weight of one or more antioxidants. soluble in oil.
  4. 4. The preparation according to one of claims 1 and 3, containing, by weight part of the retinoid, 3 to 5 parts by weight of one or more antioxidants soluble in water and 3 to 5 parts by weight of one or more antioxidants. soluble in oil.
  5. 5. The preparation according to one of claims 1 and 4, which contains, as a water-soluble antioxidant, L-ascorbic acid or salts of L-ascorbic acid.
  6. 6. The preparation according to one of claims 1 and 5, which contains α-tocopherol as an oil-soluble antioxidant.
  7. 7. The preparation according to one of claims 1 and 6, wherein the retinoid is all trans retinol.
  8. 8. The preparation according to claim 7, which contains 0.015 to 0.2% by weight of all trans retinol.
  9. 9. The preparation according to one of claims 1 to 8, wherein the UV filters are UV-A, UV-B and / or wide-band filters.
  10. 10. The preparation according to one of claims 1 and 9 in the form of an O / W, W / O or multiple emulsion.
  11. 11. The preparation according to one of claims 1 to 10, characterized in that it is stored in oxygen-impermeable containers without the addition of protective gas.
  12. 12. The preparation according to one of claims 1 to 11, characterized in that it is a preparation for the care of the skin.
MXPA/A/2006/008185A 2004-01-22 2006-07-19 Retinoid-containing preparations MXPA06008185A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004003478.8 2004-01-22

Publications (1)

Publication Number Publication Date
MXPA06008185A true MXPA06008185A (en) 2007-04-10

Family

ID=

Similar Documents

Publication Publication Date Title
US20070202060A1 (en) Retinoid-Containing Preparations
KR101290853B1 (en) Composition with tight capsules containing a sunscreen agent
US6391289B2 (en) Use of sunscreen combinations comprising, as essential constituent, 4,4′-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations
ES2634638T3 (en) Use of troxerutin to deactivate fluorescence of disodium phenyldibenzimidazole tetrasulfonate
JPH0710750A (en) Compound for cosmetics or skin science containing delta- aminolive phosphoric acid
JP2008518988A (en) Additives for UV-sunscreen preparations
JP2006514661A (en) Novel stabilized cinnamate sunscreen composition
KR20080081961A (en) Novel cosmetic or dermatological combinations comprising modified titanium dioxide particles
JP2001064116A (en) Water in oil type low viscosity cosmetic or dermatologic preparation
JP4829795B2 (en) Photoprotective composition containing a UV filter based on polysiloxane and having a reduced total amount of UV filter
US20080020054A1 (en) Cosmetic and Dermatological Preparations Containing Transparent Surface-Coated Titanium Dioxide Particles
US6458342B1 (en) Use of sunscreen combinations comprising, as essential constituent, 2,2′-p-phenylenebis (3,1-benzoxazin-4-one) as photostable UV filters in cosmetic and pharmaceutical preparations
AU2461302A (en) Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photostable UV filters in cosmetic and pharmaceutical preparations
EP2301519A1 (en) Ultraviolet absorbing composition
US20050202049A1 (en) Retinoid-containing preparations
US20020015718A1 (en) Use of physiologically compatible sulfinic acids as antioxidant or free-radical scavenger in cosmetic or dermatological preparations
JP6899652B2 (en) Topical skin composition
MXPA06008185A (en) Retinoid-containing preparations
WO2005048970A1 (en) Use of lignans in cosmetic or dermatological preparations
US20070028401A1 (en) Powdered preparations containing a mixture of 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate
KR20180130543A (en) 10-hydroxystearic acid composition
JPH1087465A (en) Usage of dibenzoylmethane derivative for accomplishment or enhancement of solubility of triazine derivative in oil constituent
JP5247029B2 (en) A mixture comprising a UV-A filter and a UV-B filter
US20230381074A1 (en) Organic sunscreen composition and process for protecting skin from photodamage and aging
US6703001B1 (en) Cosmetic and dermatological light-protective formulations containing triazine derivatives one or several esters of branched-chain carboxylic acids and branched-chain alcohols